Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Brain, Behavior, & Immunity - Health|June 9, 2023
Interaction between peripheral and central immune markers in clinical high risk for psychosisKankana Nisha Aji, Sina Hafizi, Tania Da Silva, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 22, 2016
Inhibition of fatty acid amide hydrolase by BIA 10-2474 in rat brainJunchao Tong, Romina Mizrahi, Sylvain Houle, et al.
Human Brain Mapping|February 18, 2010
Optimal transcranial magnetic stimulation coil placement for targeting the dorsolateral prefrontal cortex using novel magnetic resonance image-guided neuronavigationPablo M Rusjan, Mera S Barr, Faranak Farzan, et al.
Clinical EEG and Neuroscience|August 30, 2008
Evaluating the relationship between long interval cortical inhibition, working memory and gamma band activity in the dorsolateral prefrontal cortexZafiris J Daskalakis, Faranak Farzan, Mera S Barr, et al.
Journal of Psychiatry & Neuroscience : JPN|September 27, 2018
GABA levels and TSPO expression in people at clinical high risk for psychosis and healthy volunteers: a PET-MRS studyTania Da Silva, Sina Hafizi, Pablo M Rusjan, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 13, 2014
Kinetic modeling of the monoamine oxidase B radioligand [¹¹C]SL25.1188 in human brain with high-resolution positron emission tomographyPablo M Rusjan, Alan A Wilson, Laura Miler, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 29, 2019
Prefrontal cortical dopamine release in clinical high risk for psychosis during a cognitive task: a [<sup>11</sup>C]FLB457 positron emission tomography studyAbanti Tagore, Christin Schifani, Naren Rao, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 30, 2016
Heightened Dopaminergic Response to Amphetamine at the D<sub>3</sub> Dopamine Receptor in Methamphetamine UsersIsabelle Boileau, Doris Payer, Pablo M Rusjan, et al.
The European Journal of Neuroscience|July 10, 2026
Group Differences of Multiregion Glutamate Concentration in Clinical High Risk and SchizophreniaShue Kit Man, M Belen Blasco, Razieh Alemi, et al.
Schizophrenia Bulletin|October 17, 2017
Nigral Stress-Induced Dopamine Release in Clinical High Risk and Antipsychotic-Naïve SchizophreniaHuai-Hsuan Tseng, Jeremy J Watts, Michael Kiang, et al.
Pageof 7